Literature DB >> 1120468

Cycloleucine transport in isolated rat thymocytes: in vitro effects of triiodothyronine and thyroxine.

I D Goldfine, C G Simons, G J Smith, S H Ingbar.   

Abstract

Thymocytes obtained from suckling or young adult rats were used as a model system to study the action of thyroid hormones in vitro. In this tissue, L-triiodothyronine (T3) increased the uptake of the non-metabolizable amino acids, alpha-aminoisobutyrate and cycloleucine. A detectable effect of T3 on the uptake of cycloleucine was seen at a concentration of 0.1 muM and maximum effects were seen at 20 muM. Thyroxine (T4) also increased cycloleucine uptake with about one-third the potency of T3, and this effect could not be ascribed to conversion of T4 to T3. In contrast, L-monoidotyrosine and L-diiodotyrosine were without effects on transport. Kinetic studies indicated that T3 enhanced uptake by inhibiting amino acid efflux; no effect was seen on influx. The effect of T3 on amino acid uptake was evident within 1 min, and was not inhibited by either prior treatment of the cells with cycloheximide or by lowering the incubation temperature from 37 to 24 C. In other studies, when T3 was injected into rats in vivo at a dose of 20 mug/100 g, the uptake of cycloleucine was enhanced in thymocytes obtained 1 h later. These data suggest that thyroid hormones can directly influence amino acid transport in rat thymocytes. This effect is prompt, is independent of new protein synthesis, and may reflect a direct interaction with specific components of the cell membrane.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1120468     DOI: 10.1210/endo-96-4-1030

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  9 in total

1.  Solubilization and purification of a membrane-associated 3,3',5-tri-iodo-L-thyronine-binding protein from rat erythrocytes.

Authors:  R C Angel; J A Botta; R D Morero; R N Farias
Journal:  Biochem J       Date:  1990-09-15       Impact factor: 3.857

2.  Nuclear receptors for thyroid hormone.

Authors:  L J DeGroot; S Refetoff; J Bernal; P A Rue; A H Coleoni
Journal:  J Endocrinol Invest       Date:  1978-01       Impact factor: 4.256

3.  Nonlinear (amplified) relationship between nuclear occupancy by triiodothyronine and the appearance rate of hepatic alpha-glycerophosphate dehydrogenase and malic enzyme in the rat.

Authors:  J H Oppenheimer; P Coulombe; H L Schwartz; N W Gutfeld
Journal:  J Clin Invest       Date:  1978-04       Impact factor: 14.808

4.  Beta-adrenergic potentiation of the increased in vitro accumulation of cycloleucine by rat thymocytes induced by triiodothyronine.

Authors:  J Etzkorn; P Hopkins; J Gray; J Segal; S H Ingbar
Journal:  J Clin Invest       Date:  1979-06       Impact factor: 14.808

5.  Enhancement by glucocorticoid deficiency of the increase in cycloleucine accumulation induced in rat thymocytes by triiodothyronine.

Authors:  J R Etzkorn; P Hopkins; D Gluckin; J Gray; I D Goldfine; S H Ingbar
Journal:  J Endocrinol Invest       Date:  1979 Oct-Dec       Impact factor: 4.256

6.  Early changes in brush border disaccharidase kinetics in rat jejunum following subcutaneous administration of tetraiodothyronine: a quantitative histochemical study on villi revealing normal morphology.

Authors:  S Gutschmidt; C Emde
Journal:  Histochemistry       Date:  1981

7.  Stimulation by triiodothyronine of the in vitro uptake of sugars by rat thymocytes.

Authors:  J Segal; S H Ingbar
Journal:  J Clin Invest       Date:  1979-03       Impact factor: 14.808

Review 8.  Involvement of Thyroid Hormones in Brain Development and Cancer.

Authors:  Gabriella Schiera; Carlo Maria Di Liegro; Italia Di Liegro
Journal:  Cancers (Basel)       Date:  2021-05-30       Impact factor: 6.639

Review 9.  Genomic and Non-Genomic Mechanisms of Action of Thyroid Hormones and Their Catabolite 3,5-Diiodo-L-Thyronine in Mammals.

Authors:  Marco Giammanco; Carlo Maria Di Liegro; Gabriella Schiera; Italia Di Liegro
Journal:  Int J Mol Sci       Date:  2020-06-10       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.